13.23 -0.02 (-0.15%)
BMTI
Stock Details
Last Trade:13.23 Change:-0.02 (-0.15%) Prev Close:13.25 Open: 13.33 Days Range:13.04 – 13.35 52 Week Range: 6.52 - 15.81 Volume:108188 P/E: N/AEPS:-1.76
View AllRecent Alerts 03/20/10
Recent Alert on 03/16/10 at 8:42am
Wedbush Reiterates an 'Outperform' on BioMimetic Therapeutics (BMTI); Raises PT
Wedbush Reiterates an 'Outperform' on BioMimetic Therapeutics (BMTI); Raises PT
Wedbush reiterates an 'Outperform' on BioMimetic Therapeutics (Nasdaq: BMTI), raises price target to $24. Wedbush analyst says, "...We believe that the data will be accepted by the FDA for review and will support approval for ABG in the hindfoot... Read More
Recent Alert on 03/12/10 at 7:12am
BioMimetic Therapeutics Inc. (BMTI) Posts Q4 EPS of $0.05, Tops Views; Guides FY10 Net Loss
BioMimetic Therapeutics Inc. (BMTI) Posts Q4 EPS of $0.05, Tops Views; Guides FY10 Net Loss
Recent Alert on 02/17/10 at 5:38pm
BioMimetic (BMTI) Submits Third and Final Module of Premarket Approval Application for Augment(TM) Bone Graft
BioMimetic (BMTI) Submits Third and Final Module of Premarket Approval Application for Augment(TM) Bone Graft
Recent Alert on 02/17/10 at 5:38pm
BioMimetic (BMTI) Submits Third and Final Module of Premarket Approval Application for Augment(TM) Bone Graft
BioMimetic (BMTI) Submits Third and Final Module of Premarket Approval Application for Augment(TM) Bone Graft
Recent Alert on 01/06/10 at 4:16pm
BioMimetic (BMTI) Amends Agreement With Novartis, Extended For 3 Years
BioMimetic (BMTI) Amends Agreement With Novartis, Extended For 3 Years
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 10/14/09 at 12:09pm
BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics
BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics